In France, the Levothyrox case is an extremely mediated pharmacovogilance case which received a lot of media coverage in August 2017 following the change, in March of the same year, of the pharmaceuti

Zenodo2022-12-05 更新10

Risk of drug-induced delirium in older patients- a pharmacovigilance study of FDA adverse event reporting system database

药物警戒

老年患者

Drug-induced delirium is known risk factors associated with increased morbidity and mortality in older patients. The objective was to evaluate the risk of drug-related delirium in older patients based

Taylor & Francis Group2025-01-02 更新10

Toxicity profiles associated with EGFR-TKIs combined with angiogenesis inhibitors in non-small cell lung cancer: an epidemiological surveillance analysis of the FDA adverse event reporting system

毒性

药物警戒

Ongoing studies are evaluating the efficacy and toxicity profiles of combining epidermal growth factor receptor inhibitors (EGFR-TKIs) with antiangiogenic agents in non-small cell lung cancer (NSCLC).

Taylor & Francis Group2025-10-02 更新20

Table_1_Lung Cancer Adverse Events Reports for Angiotensin-Converting Enzyme Inhibitors: Data Mining of the FDA Adverse Event Reporting System Database.docx

药物警戒

不良反应信号检测

Because of contradictory evidence from clinical trials, the association between angiotensin-converting enzyme inhibitors (ACEIs) and lung cancer needs further evaluation. As such, the current study is

NIAID Data Ecosystem10

Summary of drug-related adverse events by system organ class.

资源简介：

相关数据集